drug

eliglustat tartrate

Marketedupdated 2mo ago

by Aizant Drug Research Solutions Pvt Ltd

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Nov 24, 2030

~4.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

Dec 13, 2038method-of-use (U-3040)US 10888544
Jun 5, 2032method-of-use (U-3043)US 12465586
Jan 31, 2031method-of-use (U-3043)US 108885474.6y
Nov 24, 2030compositionUS 114581194.4y
Jun 26, 2026compositionUS 7196205

Data sources

ClinicalTrials.gov

last refreshed 56m ago

Found something off?